Literature DB >> 3450386

Overt hydrocephalus at birth--origin and outcome.

E Fernell1, P Uvebrant, L von Wendt.   

Abstract

Based on a survey of the population, which included 202 infants with infantile hydrocephalus those who had had overt hydrocephalus at birth were selected and analyzed with respect to origin and outcome. The present series consisted of 47 infants (23% of the total series), 83% of whom were born at term and 17% before term. In the study period 1967-1982, the prevalence was 0.12/1,000 births. Among infants with maldevelopment of the CNS and/or other organs, the mortality before 2 years of age was 37%, and among the survivors the rate of neurological sequelae was 88%. The corresponding figures for infants with uncomplicated hydrocephalus, i.e., without other maldevelopment, was 20% and 44%, respectively. The prognosis was especially poor for infants born before term. It was concluded that the prognosis was largely determined by maldevelopment affecting the CNS macro- or microarchitecture.

Entities:  

Mesh:

Year:  1987        PMID: 3450386     DOI: 10.1007/BF00270705

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

1.  Epidemiology of infantile hydrocephalus in Sweden. II. Origin in infants born at term.

Authors:  E Fernell; B Hagberg; G Hagberg; L von Wendt
Journal:  Acta Paediatr Scand       Date:  1987-05

2.  Epidemiology of infantile hydrocephalus in Sweden. III. Origin in preterm infants.

Authors:  E Fernell; B Hagberg; G Hagberg; L von Wendt
Journal:  Acta Paediatr Scand       Date:  1987-05

3.  Fetal and infant mortality associated with congenital malformations.

Authors:  I D Richards
Journal:  Br J Prev Soc Med       Date:  1973-05

4.  The prognosis of hydrocephalus overt at birth.

Authors:  J Mealey; R L Gilmor; M P Bubb
Journal:  J Neurosurg       Date:  1973-09       Impact factor: 5.115

5.  The epidemiology of congenital hydrocephalus. A study in Brooklyn, N.Y. 1968--1976.

Authors:  S C Stein; J G Feldman; S Apfel; S G Kohl; G Casey
Journal:  Childs Brain       Date:  1981

6.  Heterogeneity of prenatal onset hydrocephalus: management and counseling implications.

Authors:  R A Williamson; C W Schauberger; M W Varner; C A Aschenbrener
Journal:  Am J Med Genet       Date:  1984-02

7.  Prognostic signs in fetal hydrocephalus.

Authors:  W Serlo; P Kirkinen; P Jouppila; R Herva
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

8.  Current prognosis in overt neonatal hydrocephalus.

Authors:  D C McCullough; L A Balzer-Martin
Journal:  J Neurosurg       Date:  1982-09       Impact factor: 5.115

9.  Epidemiology of infantile hydrocephalus in Sweden. I. Birth prevalence and general data.

Authors:  E Fernell; B Hagberg; G Hagberg; L von Wendt
Journal:  Acta Paediatr Scand       Date:  1986-11

10.  The relationship between intellectual skills and the computerised axial tomograms of children with spina bifida and hydrocephalus.

Authors:  A P Lonton
Journal:  Z Kinderchir Grenzgeb       Date:  1979-12
View more
  5 in total

1.  Pre- and neonatal hydrocephalus in the Middle East: experience in Qatar.

Authors:  G J Nogueira
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

2.  Months and days fly like arrows.

Authors:  K Sato
Journal:  Childs Nerv Syst       Date:  1996-08       Impact factor: 1.475

Review 3.  Hydrocephalus--revision of its definition and classification with special reference to "intractable infantile hydrocephalus".

Authors:  K Mori
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

4.  Diagnosis, outcome, and management of fetal abnormalities: fetal hydrocephalus.

Authors:  Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2003-08-14       Impact factor: 1.475

5.  Hydrocephalus in children born in 1999-2002: epidemiology, outcome and ophthalmological findings.

Authors:  Eva-Karin Persson; Susann Anderson; Lars-Martin Wiklund; Paul Uvebrant
Journal:  Childs Nerv Syst       Date:  2007-04-12       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.